{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:00:07Z","timestamp":1791212407048,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1080\/14653240410005348","type":"journal-article","created":{"date-parts":[[2004,12,28]],"date-time":"2004-12-28T01:07:03Z","timestamp":1104196023000},"page":"554-562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["GMP production and testing of Xcellerated T Cells\u2122 for the treatment of patients with CLL"],"prefix":"10.1016","volume":"6","author":[{"given":"L.S.","family":"Hami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Leshinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Markham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1080\/14653240410005348_bib0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.12665\/J26.Hami","article-title":"Comparison of a static process and a bioreactor-based process for the GMP manufacture of autologous Xcellerated T Cells for clinical trials","volume":"2","author":"Hami","year":"2003","journal-title":"Bioproc J"},{"key":"10.1080\/14653240410005348_bib0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0167-5699(90)90085-N","article-title":"Role of the CD28 receptor in T-cell activation","volume":"11","author":"June","year":"1990","journal-title":"Immunol Today"},{"key":"10.1080\/14653240410005348_bib0015","series-title":"Fundamental Immunology","first-page":"367","article-title":"T-lymphocyte differentiation and biology","author":"Benoist","year":"1999"},{"key":"10.1080\/14653240410005348_bib0020","series-title":"Handbook of Growth Factors","article-title":"Interleukins and cytokines","author":"Pimental","year":"1994"},{"key":"10.1080\/14653240410005348_bib0025","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0161-5890(80)90156-X","article-title":"Functional and molecular characteristics of T-cell growth factor","volume":"17","author":"Smith","year":"1980","journal-title":"Mol Immunol"},{"key":"10.1080\/14653240410005348_bib0030","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-065X.1980.tb00327.x","article-title":"T-cell growth factor","volume":"51","author":"Smith","year":"1980","journal-title":"Immunol Rev"},{"key":"10.1080\/14653240410005348_bib0035","series-title":"Guidebook to Cytokines and their Receptors","first-page":"27","article-title":"Interleukin-2","author":"Goldsmith","year":"1994"},{"key":"10.1080\/14653240410005348_bib0040","series-title":"Guidebook to Cytokines and their Receptors","first-page":"31","article-title":"Interleukin-2 receptor","author":"Voss","year":"1994"},{"key":"10.1080\/14653240410005348_bib0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.immunol.16.1.111","article-title":"CD40 and CD 154 in cell mediated immunity","volume":"16","author":"Grewal","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1080\/14653240410005348_bib0050","series-title":"The Cytokine Handbook","first-page":"517","article-title":"Tumor necrosis factor","author":"Zhang","year":"2000"},{"key":"10.1080\/14653240410005348_bib0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s002620050409","article-title":"Active and indolent chronic lymphocytic leukaemia: immune and hormonal peculiarities","volume":"45","author":"Everaus","year":"1997","journal-title":"Cancer Immunol Immunother"},{"issue":"11","key":"10.1080\/14653240410005348_bib0060","first-page":"109a","article-title":"A phase I\/II trial of Xcellerated T cells in patients with chronic lymphocytic leukemia","volume":"102","author":"Kipps","year":"2003","journal-title":"Blood"},{"key":"10.1080\/14653240410005348_bib0065","first-page":"484","article-title":"Redirected lysis assay to measure cytolytic function of Xcellerated T cells and its correlation with induction of cytokines and upregulation of cell surface markers","volume":"4","author":"Leshinsky","year":"2002","journal-title":"Cytotherapy"},{"key":"10.1080\/14653240410005348_bib0070","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1089\/10430340050015202","article-title":"Retrovirus-mediated gene transfer in primary T lymphocytes: influence of the transductionuselection process and of ex vivo expansion on the T-cell receptor beta chain hypervariable region repertoire","volume":"11","author":"Ferrand","year":"2000","journal-title":"Hum Gene Ther"},{"key":"10.1080\/14653240410005348_bib0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nm0298-215","article-title":"Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy","volume":"4","author":"Gorochov","year":"1998","journal-title":"Nature Med"},{"key":"10.1080\/14653240410005348_bib0080","first-page":"417","article-title":"Four-color flow cytometric detection of residual malignant B cells for lot release of Xcellerated T Cells\u2122 for infusion into patients with chronic lymphocytic leukemia","volume":"6","author":"Green","year":"2004","journal-title":"Cytotherapy"},{"key":"10.1080\/14653240410005348_bib0085","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1365-2141.2003.04036.x","article-title":"Assessing diversity: immune reconstitution and T-cell receptor BV spectratype analysis following stem cell transplantation","volume":"120","author":"Peggs","year":"2003","journal-title":"Brit J Haematol"},{"key":"10.1080\/14653240410005348_bib0090","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1046\/j.1365-2141.2001.02871.x","article-title":"Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion","volume":"113","author":"Mariani","year":"2001","journal-title":"Brit J Haematol"},{"key":"10.1080\/14653240410005348_bib0095","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1182\/blood.V96.6.2299","article-title":"Recovery of immune reactivity after T-cell-depleted bone marrow trans plantation depends on thymic activity","volume":"96","author":"Roux","year":"2000","journal-title":"Blood"},{"key":"10.1080\/14653240410005348_bib0100","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1172\/JCI119601","article-title":"Characterization of T-cell repertoire in patients with graft-versus- leukemia after donor lymphocyte infusion","volume":"100","author":"Claret","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1080\/14653240410005348_bib0105","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1182\/blood.V91.11.4224","article-title":"Correction of abnormal T-cell receptor repertoire during interferon-alpha therapy in patients with hairy cell leukemia","volume":"91","author":"Kluin-Nelemans","year":"1998","journal-title":"Blood"},{"key":"10.1080\/14653240410005348_bib0110","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1182\/blood-2001-11-0005","article-title":"Distinct contributions of CD4(+) and CD8(+) naive and memory T-cell subsets to overall T-cell-receptor repertoire complexity following trans plantation of T-cell-depleted CD34-selected hematopoietic progenitor cells from unrelated donors","volume":"100","author":"Eyrich","year":"2002","journal-title":"Blood"},{"key":"10.1080\/14653240410005348_bib0115","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.4049\/jimmunol.152.10.5109","article-title":"Circulating T-cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status","volume":"152","author":"Gorski","year":"1994","journal-title":"J Immunol"},{"key":"10.1080\/14653240410005348_bib0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.immunol.20.081701.141316","article-title":"T-cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T-cell repertoire","volume":"20","author":"Kuchroo","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1080\/14653240410005348_bib0125","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/1566524013363690","article-title":"Molecular character ization of the T-cell repertoire using immunoscope analysis and its possible implementation in clinical practice","volume":"1","author":"Ria","year":"2001","journal-title":"Curr Mol Med"},{"key":"10.1080\/14653240410005348_bib0130","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/jnr.1243","article-title":"Short-term evolution of autoreactive T-cell repertoire in multiple sclerosis","volume":"66","author":"Vergelli","year":"2001","journal-title":"J Neurosci Res"},{"key":"10.1080\/14653240410005348_bib0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/08916939409014682","article-title":"Analysis of the peripheral T-cell receptor V beta repertoire in newly diagnosed patients with type I diabetes","volume":"18","author":"Wong","year":"1994","journal-title":"Autoimmunity"},{"key":"10.1080\/14653240410005348_bib0140","doi-asserted-by":"crossref","unstructured":"Bernstein WB, CoxJH, Aronson NE, et al. Immune reconstitution following autologous transfers of CD3uCD28 stimulated CD4+ T cells to HIV-infected persons. Clinical Immunol 2004; in press.","DOI":"10.1016\/j.clim.2004.03.004"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324904707689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324904707689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:09:24Z","timestamp":1761430164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324904707689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S1465324904707689"],"URL":"https:\/\/doi.org\/10.1080\/14653240410005348","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GMP production and testing of Xcellerated T Cells\u2122 for the treatment of patients with CLL","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1080\/14653240410005348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}